Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice

Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice

Although diabetic cognitive impairment is one of the most common complications of type 2 diabetes mellitus (T2DM), optimized therapeutic strategies are not available yet. Astragalosides IV (AS-IV) is a traditional Chinese medicine possessing diverse pharmacological properties including anti-inflamma...

Full description

Bibliographic Details
Main Authors: Yaxuan Zhang, Yuan Yuan, Jiawei Zhang, Yao Zhao, Yueqi Zhang, Jianliang Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Aging Neuroscience
Subjects:
astragalosides IV
cognitive impairment
type 2 diabetes mellitus
neuroinflammation
oxidative stress
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.1004557/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.1004557/full

Similar Items